Sabrina Johnson | President & CEO
Dar� Bioscience

Sabrina Martucci Johnson Founder, President & Chief Executive Officer, Daré Bioscience (NASDAQ: DARE) Sabrina Martucci Johnson doesn’t just talk about the gap in women’s health – she’s working to close it. In 2015 she founded Daré Bioscience on a straightforward thesis: the science exists, the need is real, and the market is massive. What’s been missing is execution. Under her leadership, Daré has built a pipeline of first-in-category product candidates spanning contraception, sexual health, menopause, vaginal health, and infectious disease, and is now bringing them to market. Sabrina’s edge is the combination of scientific credibility and commercial discipline. She started as a research scientist at Baxter Healthcare, moved through commercial and financial leadership at Cypress Bioscience (NASDAQ:CYPB) and WomanCare Global (as both CFO and COO), and built Daré from the ground up. She understands the biology, controls the financials, and knows how to launch. That trifecta is uncommon in any CEO. In women’s health, it’s nearly singular. She holds degrees in Biomedical Engineering (Tulane), Biochemical Engineering (University College London), and International Management (Thunderbird). She serves on the boards of AtaiBeckley, Biocom California (as chair), and BIO. Her work has been recognized by Ernst & Young Entrepreneur of the Year (Pacific Southwest), Fierce Pharma’s Most Influential People in Biopharma, the Medicine Maker Power List, and Endpoints Women in Biopharma. Women’s health has been underfunded, understudied, and underestimated for decades. Sabrina Martucci Johnson is among a small group of people actually doing something about it.